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onstrate how four European vascular centers resort to one
technical infrastructure and neuromonitoring-expertise
during TAAA OR by internet connection.
Methods: In 2009 and 2010, 121 patients were treated
by TAAAORusing identical protocols, including distal aortic
perfusion. All neurophysiological data from two centers in
Germany, one in Switzerland and one in the Netherlands
were evaluated by a central neurophysiologists team in a
Dutch Medical Center. Online assessment of MEPs was
installed using internet with Virtual Private Network Tun-
nelling. We investigated the reliability, stability and robust-
ness of this telemedical system.
Results: MEPs were monitored in all patients without
technical problems. In 61 patients a significant drop in MEPs
was recorded, requiring immediate protective adjustments. In
30 patients, blood pressure management, reposition of cross-
clamps, blocking of intercostal arteries or rewarming restored
MEPs. All other cases required reattachment of spinal cord
supplying arteries. In 59 patients the protective strategies
correctedMEPs completely. In all cases the data communica-
tion was stabile enabling successful MEPs evaluation by the
neurophysiologist in the Netherlands.
Conclusions: Remote neuromonitoring of spinal cord
function during aortic surgery is feasible and reliable. It
allows centralization of expertise and saves individual cen-
ters to invest in complex technology. The value of moni-
toring MEPs was confirmed in different centers, resulting
in adequate neurological outcome following extensive aor-
tic procedures.
Author Disclosures: S. E. Debus: Nothing to disclose; F.
Dick: Nothing to disclose; A. Greiner: Nothing to dis-
close; J. Grommes: Nothing to disclose;M. Jacobs: Noth-
ing to disclose; W. H. Mess: Nothing to disclose; J.
Schmidli: Nothing to disclose.
SS20.
Physician Modified Endovascular Grafts for the Treat-
ment of Elective, Symptomatic or Ruptured Juxtarenal
Aortic Aneurysms
Benjamin W. Starnes. University of Washington, Seattle,
WA
Objectives: To determine if a physician modified en-
dovascular graft (PMEG) is a safe and effective method of
treating juxtarenal aortic aneurysms in patients considered
to be unsuitable for open surgical repair.
Methods: A prospective, consecutively enrolling,
non-randomized single institution evaluation of the
safety and efficacy of physician modification of a cur-
rently FDA-approved device (COOK Zenith Flex) to
preserve branch vessels when used in the treatment of
patients with elective, symptomatic or ruptured juxtare-
nal aortic aneurysms.
Results: 47 consecutive patients underwent fenes-
trated endovascular repair using PMEG over a three year
period. 38 patients (80%) were symptomatic or had rapid
aneurysm expansion. 85% of patients were ASA category III
or IV. 82 fenestrations were created for 58 renal arteries, 16
SMA’s, 3 celiacs and the rest accessory vessels. Mean follow
up was 103 days (range 62-442). Mean contrast usage and
fluoro time were 98cc and 48 min. There were six compli-
cations (12.7%). Three (6.4%) were access related and three
(6.4%) were procedure related and included one stroke,
one renal failure and one branch artery dissection. On
follow up, only 6 patients (12.8%) had endoleak. Operative
mortality was 0%. In hospital and 30-day mortality was 2%
with 1 patient expiring due to aspiration on the ward after
successful endovascular repair. Two patients died during
follow up; one at 58 days due to cessation of dialysis and
one at 485 days due to stent graft migration and occlusion
of the SMA. There were two deaths in the first year, one in
the second and zero in the most recent year of experience.
One patient with endoleak had aneurysm sac expansion at 1
year requiring secondary intervention.
Conclusions: PMEG is a safe and effective alternative
for treating patients with juxtarenal aneurysms who have no
other alternatives for repair. Longer term follow up is
needed to assess the durability of repair and potential for
device-related complications.
Author Disclosures: B. W. Starnes: Nothing to disclose.
VS4.
Video Presentation
Staged Total Abdominal Debranching and TEVAR for
Thoracoabdominal Aneurysm
Richard L. McCann. Duke University Medical Center,
Durham, NC
Background: We present a video illustrating an op-
tional strategy for repair of thoracoabdominal aortic
aneurysm in patients who, because of anatomic or phys-
iologic reasons, are not good candidates for standard
open repair.
Technical Description: The video is of a 70 year old
patient who had rapid growth of a 5.8 cm visceral segment
aneurysm after 3 prior TAA/TAAA procedures. In the first
stage, total abdominal debranching was accomplished
through a midline laparotomy using a multibranched Dacron
graft (Vascutek). This graft was based on the left common iliac
artery and consists of a 14 mm trunk with appropriately sized
side limbs for the left renal, SMA, Celiac, and right renal
arteries and an integral 10 mm conduit which was buried in a
lower abdominal subcutaneous pocket. This access limb ob-
viates surgical vascular dissection during the delayed endovas-
cular stage and was easily exposed and thrombectomized to
provide access for the second stage performed 5 days later.
The TEVAR procedure required 3 overlapping and tapering
Talent (Medtronic) components to exclude the aneurysm.
Confirmation of aneurysm exclusion and branch graft patency
by subsequent CT angiogram will be shown. This patient
remains well 4 months post operatively. We have performed
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this procedure in 39 patients, judged poor risks for standard
open TAAA repair, with 10 % mortality.
Author Disclosures: R. L. McCann: Terumo, Honorar-
ium.
SS22.
Incidence and Outcomes of TAG compression with
Comparison to the c-TAG
Karthikeshwar Kasirajan. Emory University, Atlanta, GA
Objectives: The present study was undertaken to
evaluate the incidence and outcomes of infolding with
the GORE TAG® Thoracic Endoprosthesis (TAG de-
vice) and to better understand the factors that might
help predict these events.
Methods: Infolding events reported to WL Gore
(Flagstaff, AZ) on or before December 2008 related to
graft failure following the use of the TAG device were
reviewed. When available, images were analyzed by an
independent core laboratory.
Results: Between 1998 and December 2008, device
infolding was reported in 139 cases (mean patient age
4017 years, 73.4%males) in a total of 33,289 TAG device
implants (0.4% incidence). The majority of events were
noted in implants for trauma (60%) and a 26 or 28mm
diameter device was used in 74% of the procedures. Ap-
proximately half of all patients (51%) were asymptomatic
with diagnosis being made on routine chest imaging. The
median time to diagnosis was 9.5 days (0 - 2190d). A total
of 124 patients received 136 interventions, including
30 (24%) open surgical conversions and a variety of endo-
vascular techniques (40% large balloon expandable stent(s),
31% relining with additional endograft). A total of 10
patients died following device infolding, all of which re-
ceived one or more interventions to attempt to repair the
infolded device. The newConformable GORETAG device
has been modified to prevent this event with 1400 im-
plants in Europe with 550 and 6-month follow-up with no
reports of compression.
Conclusions: TAG device infolding is an infrequent
event that occurs predominantly in young patients with
small aortic diameters and tight arch curvature. This
appears primarily related to excessive device oversizing
compounded by the high peak blood flow velocities of
young patients and a lack of inner curvature apposition.
The newer c-TAG in short-term follow up appears to have
overcome the compression events.
Author Disclosures: K. Kasirajan: WL Gore, Research
Grants.
SS23.
Contemporary Results of Open Complex Abdominal
Aortic Aneurysm Repair Using a Standardized Classi-
fication for Comparison with Fenestrated Endografts
Gustavo S. Oderich, Tiziano Tallarita, Manju Kalra, Audra
A. Duncan, Peter Gloviczki, Terri Vrtiska, Steve Cha,
Thomas C. Bower. Division of Vascular and Endovascular
Surgery, Mayo Clinic, Rochester, MN
Objectives: This study analyzed outcomes of open
repair of complex abdominal aortic aneurysms (cAAA)
based upon an anatomic and endovascular classification
system, thereby providing a standard of comparison for
fenestrated endovascular repair (FEVAR).
Methods: We reviewed outcomes of 461 patients who
underwent open cAAA repair (2000-2010). Pre-operative
digital imaging was analyzed by a blinded investigator using
centerline of flow to define aneurysm extent and the ex-
pected number of fenestrations that would be required to
provide 2-cm of proximal seal for FEVAR. End-points were
mortality, morbidity, renal function (RF) deterioration,
re-interventions, and patient survival.
Results: There were 354 male and 107 female patients
withmean age of 738 years. Operative mortality was 1.3%
(6/461). Any morbidity occurred in 260 patients (57%),
and was severe (SVS 3) in 91 (20%). Five-year patient
survival, freedom from re-intervention, and freedom from
RF deterioration were 723%, 902%, and 843%. In-
creasing level of aneurysm complexity (see table) was asso-
ciated with greater mortality, severe morbidity and dialysis
rates using either classification system (P0.001).
Conclusions: Open cAAA repair can be performed
safely with low mortality (1.3%) but high risk of complica-
tions. These data stratified by anatomic classification and
the expected number of fenestrations provide a benchmark
for comparison with results of FEVAR.













Juxtarenal 235 0 30 (13) 5 (2) 89  6 92  2 764
Suprarenal 175 2 (1.1) 38 (22) 9 (5) 82  5 88  4 69  5
Type IV TAAA 51 4 (7.8) 22 (43) 7 (14) 64  11 81  8 62  10
Expected Number of Fenestrations
One 7 0 0 0 75  21 100 67  3
Two 214 0 31 (14) 4 (2) 92  3 92  3 76  4
Three 118 1 (0.8) 20 (17) 7 (6) 72  8 90  5 63  7
Four 74 5 (6.7) 31 (42) 8 (11) 72  9 84  6 71  8
Total 461 6 (1.3) 91 (20) 21 (4.5) 84  3 90  2 72  3
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